Oxaliplatin: its use in epithelial ovarian carcinoma

被引：0
|
作者：
Bermudez, A [1 ]
Snaidas, L [1 ]
Paniceres, G [1 ]
Sardi, J [1 ]
机构：
[1] Univ Hosp, Gynecol Oncol Unit, Buenos Aires, DF, Argentina
来源：
7TH BIENNIAL MEETING OF THE INTERNATIONAL GYNECOLOGIC CANCER SOCIETY | 1999年
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
The aims of this study were to evaluate the response and toxicity rates of this new platinum analogue in patients with advanced or recurrent epithelial ovarian carcinoma.
引用
收藏
页码：187 / 190
页数：4
相关论文
共 50 条
  • [31] Altered glutathione metabolism in oxaliplatin resistant ovarian carcinoma cells
    ElAkawi, Z
    AbuHadid, M
    Perez, R
    Glavy, J
    Zdanowicz, J
    Creaven, PJ
    Pendyala, L
    CANCER LETTERS, 1996, 105 (01) : 5 - 14
  • [32] CLINICAL DIFFERENCES BETWEEN EPITHELIAL OVARIAN CARCINOMA AND ENDOMETRIOSIS ASSOCIATED OVARIAN CARCINOMA
    Gungor, T.
    Ozgu, E.
    Ayhan, S.
    Yalcin, H.
    Ozgu, B. Salman
    Erkaya, S.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2013, 23 (08)
  • [33] Use of serum copper and zinc levels in the diagnostic evaluation of endometrioma and epithelial ovarian carcinoma
    Korun, Z. E. Utkan
    Erdem, M.
    Erdem, A.
    Onan, A.
    Bozkurt, N.
    Oktem, M.
    Biberoglu, K.
    CESKA GYNEKOLOGIE-CZECH GYNAECOLOGY, 2023, 88 (04): : 279 - 286
  • [34] Socioeconomic factors may contribute to neoadjuvant chemotherapy use in metastatic epithelial ovarian carcinoma
    Chase, Dana M.
    Rincon, Alejandrina
    Deane, Molly
    Tewari, Krishnansu S.
    Brewster, Wendy R.
    GYNECOLOGIC ONCOLOGY, 2009, 115 (03) : 339 - 342
  • [35] The role of the REG4 gene and its encoding product in ovarian epithelial carcinoma
    Shuo Chen
    Wen-Feng Gou
    Shuang Zhao
    Zhe-Feng Niu
    Yang Zhao
    Yasuo Takano
    Hua-Chuan Zheng
    BMC Cancer, 15
  • [36] The role of the REG4 gene and its encoding product in ovarian epithelial carcinoma
    Chen, Shuo
    Gou, Wen-Feng
    Zhao, Shuang
    Niu, Zhe-Feng
    Zhao, Yang
    Takano, Yasuo
    Zheng, Hua-Chuan
    BMC CANCER, 2015, 15
  • [37] Single agent activity of oxaliplatin in heavily pretreated advanced epithelial ovarian cancer
    Chollet, P
    Bensmaine, MA
    Brienza, S
    Deloche, C
    Cure, H
    Caillet, H
    Cvitkovic, E
    ANNALS OF ONCOLOGY, 1996, 7 (10) : 1065 - 1070
  • [38] Current management of epithelial ovarian carcinoma: A review
    Marsden, DE
    Friedlander, M
    Hacker, NF
    SEMINARS IN SURGICAL ONCOLOGY, 2000, 19 (01): : 11 - 19
  • [39] Epithelial ovarian carcinoma in the reproductive age group
    Duska, LR
    Chang, YC
    Flynn, CE
    Chen, AH
    Goodman, A
    Fuller, AF
    Nikrui, N
    CANCER, 1999, 85 (12) : 2623 - 2629
  • [40] Octreotide: an active agent in epithelial ovarian carcinoma?
    Jones, RH
    Reubi, JC
    Milian, D
    Vasey, P
    LANCET ONCOLOGY, 2004, 5 (04): : 251 - 253
12345